NUE vs STRO · P/E 25, rev $7.08B vs rev $62.0M
Nucor Corp (NUE) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Nucor Corp (NUE) is a steel company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported NUE revenue for 2024-12-31 was $7.08B. Net income was $345.0M. Revenue was down 4.9% from 2024-09-28 to 2024-12-31. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
NUE currently screens at market cap $57.53B and trailing P/E 25.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the NUE and STRO stock pages for the full models.
Not investment advice.